Lu Cheng
Key Laboratory Of Preclinical Study For New Drugs Of Gansu Province
Lanzhou, China
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Peptide DHα-(4-pentenyl)-ANPQIR-NH2 Exhibits Antifibrotic Activity in Multiple Pulmonary Fibrosis Models Induced by Particulate and Soluble Chemical Fibrogenic Agents.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 24, 2023
The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-β/Smad and RAF/ERK Pathways.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 22, 2023
The aquaporin MePIP2;7 improves MeMGT9-mediated Mg2 + acquisition in cassava.
Journal: Journal of integrative plant biology
Published: February 20, 2023
A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis.
Journal: Acta pharmaceutica Sinica. B
Published: April 24, 2022
DR7dA, a Novel Antioxidant Peptide Analog, Demonstrates Antifibrotic Activity in Pulmonary Fibrosis In Vivo and In Vitro.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 21, 2021
Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: July 09, 2021
The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis.
Journal: Acta pharmaceutica Sinica. B
Published: May 20, 2020
Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress.
Journal: Toxicology and applied pharmacology
Published: June 03, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026